The drugmaker Eli Lilly will begin selling a cheaper version of its most popular insulin, Humalog, in an effort to head off criticism about the rising costs of prescription drugs, the company said Monday.
Trending:
Eli Lilly will sell half-price version of Humalog, its popular insulin